The global geriatric medicine market size was valued at USD 179.76 billion in 2025 and is projected to grow from USD 192.88 billion in 2026 to USD 338.91 billion by 2034, registering a CAGR of 7.3% during the forecast period from 2026 to 2034. North America dominated the geriatric medicine market with a market share of 38.45% in 2025.
Geriatric medicine is a specialized branch of medicine focused on the healthcare of elderly individuals, typically those aged 65 and above. It addresses the prevention, diagnosis, treatment, and management of diseases and disabilities common in older adults. Geriatricians consider the unique medical needs of aging patients, including multiple chronic conditions, cognitive decline, mobility issues, and polypharmacy. The goal is to improve quality of life, maintain functional independence, and provide holistic care through interdisciplinary approaches that often involve social, psychological, and environmental support alongside medical treatment.
Download a Free Sample To learn more about this report,
Increasing Shift Toward Person-Centered and Integrated Geriatric Care
The geriatric medicine market is shifting from disease-specific treatment toward person-centered care models that consider multiple health conditions, functional ability, mental well-being, and social needs together. Healthcare systems are increasingly adopting comprehensive geriatric assessments and coordinated care pathways to create individualized treatment plans for older adults. This transition is shaping geriatric medicine market trends as providers place greater emphasis on maintaining independence, preventing functional decline, and coordinating medical and social support rather than treating isolated conditions.
In September 2025, the World Health Organization released the second edition of its Integrated Care for Older People (ICOPE) handbook. The guidance provides practical pathways for primary and community care workers to identify declines in intrinsic capacity, assess social-care needs, and develop personalized care plans for older adults.
Growing Adoption of Digital and Home-Based Geriatric Care
Geriatric care is also moving toward home-based models supported by digital health technologies. Telemedicine, web-based assessments, remote monitoring, and other digital tools can help healthcare professionals maintain continuity of care while reducing the need for frequent hospital visits. This structural shift is particularly relevant for older adults with mobility limitations or multiple chronic conditions and is supporting geriatric medicine market growth as healthcare systems explore ways to deliver more personalized care outside traditional clinical settings.
In May 2025, researchers from the MULTIPLAT_AGE network published recommendations for a digital-health program based on comprehensive geriatric assessment for managing older people at home. The program combined multidimensional assessment with a web-based platform to support personalized healthcare interventions under an aging-in-place model.
Expansion of the Global Older Adult Population
The expanding older population is increasing the underlying need for geriatric healthcare, as aging is associated with a higher likelihood of chronic diseases and multiple health conditions. Healthcare systems therefore require medicines, disease-management services, rehabilitation, preventive interventions, and specialized care pathways designed for older adults. This demographic shift provides a broad and sustained foundation for geriatric medicine market demand, particularly as health systems adapt services to longer life expectancy.
In October 2025, the World Health Organization reported that the global population aged 60 years and older is projected to reach 1.4 billion by 2030 and 2.1 billion by 2050. WHO also identified conditions including diabetes, dementia, osteoarthritis, and chronic respiratory disease among common health issues associated with older age.
Limited Access to Trained Geriatric Care Workforce
The expansion of geriatric services is constrained by the need for appropriately trained healthcare professionals capable of managing multimorbidity, frailty, polypharmacy, rehabilitation, and other age-related needs. Long-term care also requires coordination between medical professionals, caregivers, and social-support services. Shortages in trained personnel can limit service availability and make it difficult for healthcare systems to expand specialized geriatric programs at the pace required by aging populations.
In 2025, the World Health Organization emphasized that sustainable long-term-care systems require an appropriately trained workforce and support for caregivers, alongside quality standards and integrated care. The guidance highlights workforce development as a central requirement for expanding long-term care for older people.
Expansion of Digital Tools for Dementia and Chronic Disease Management
Digital healthcare creates opportunities for providers to extend geriatric services beyond hospitals and clinics. Telemedicine, remote consultations, medication reminders, monitoring technologies, and digital care platforms can support older adults and caregivers while improving access to specialized services. These capabilities create geriatric medicine market opportunities in home-based care, particularly for patients requiring continuing support for dementia and other chronic conditions.
In November 2025, WHO/Europe published findings from a study showing that telemedicine and telehealth can support people living with dementia and their caregivers. The review examined nearly 100 reviews and close to 3,000 records and found potential benefits including improved access to care and support for mental and cognitive health, while also emphasizing the importance of community support and age-friendly implementation.
Addressing Digital Accessibility and Health Inequalities Among Older Adults
The growing use of digital healthcare introduces challenges related to accessibility, usability, digital literacy, privacy, and unequal access to technology. Older adults may have different levels of familiarity with digital platforms, while people in underserved areas can face additional infrastructure and affordability barriers. Healthcare providers therefore need to ensure that digital geriatric solutions complement rather than exclude patients who have difficulty accessing technology.
In 2025, a mixed-methods study of older adults in India examined the use of AI-enabled healthcare and telemedicine. The research found that adoption varied between urban and rural participants and identified accessibility, digital literacy, cost, and ethical concerns as barriers to wider adoption.
Antihypertensives Segment Led the Geriatric Medicine Market with an 18.4% Share in 2025
Antihypertensives accounted for the largest share of the geriatric medicine market in 2025, representing 18.4% and an estimated value of $33.08 billion. High blood pressure is common among older adults and often requires long-term medication management, making antihypertensive drugs an important part of geriatric care. The growing elderly population and increasing need for continuous management of chronic conditions are supporting demand for these medicines.
Antidiabetics represented 15.1% of the market, valued at approximately $27.14 billion, while analgesics accounted for 14.25%, worth around $25.62 billion. Statins contributed 13.35%, followed by anticoagulants at 9.2% and proton pump inhibitors at 8.55%. Antidepressants, antipsychotics, and other therapeutic categories also contribute to the market as older adults often require treatment for multiple chronic and age-related conditions. The increasing focus on comprehensive geriatric care is supporting demand across these medication categories.
Request Customizationto receive a tailored report.
Cancer Segment is Projected to Register the Fastest Growth at a CAGR of 8.31%
The cancer segment is projected to be the fastest-growing therapeutic condition in the geriatric medicine market, with a CAGR of 8.31% during 2026–2034. Cancer risk generally increases with age, making oncology treatment an important component of healthcare for older adults. Improvements in diagnosis, treatment options, and supportive care are helping expand treatment opportunities for elderly patients while increasing demand for therapies designed to address age-related treatment considerations.
Cardiovascular conditions accounted for the largest share at 27.3%, representing approximately $49.07 billion. Arthritis represented 16.85%, while neurological conditions accounted for 14.95%. Osteoporosis contributed 9.6%, reflecting the importance of bone-health management among older adults, while respiratory conditions represented 8.75%. These conditions often require long-term management, and the increasing prevalence of multiple chronic conditions among aging populations is creating sustained demand for geriatric medicines.
Hospital Pharmacies Dominated the Geriatric Medicine Market with a 42.6% Share in 2025
Hospital pharmacies held the largest share of the geriatric medicine market in 2025, accounting for 42.6% and representing approximately $76.58 billion. Older patients frequently require multiple medications, specialist consultations, and ongoing monitoring, making hospitals an important point for accessing prescription medicines. Hospital pharmacies also play a key role in supplying treatments associated with complex or chronic conditions.
Retail pharmacies accounted for 39.25% of the market, with a value of approximately $70.56 billion. They remain an important channel for elderly patients managing long-term conditions because of their accessibility and availability of commonly prescribed medicines. Online pharmacies represented 18.15% and are expected to grow more rapidly, with a projected CAGR of 9.64%. Greater adoption of digital healthcare services, home delivery, and online prescription management is creating additional opportunities for this distribution channel.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global geriatric medicine market, representing 38.45% of total revenue and reaching USD 69.12 billion in 2025. The region continues to lead due to its growing elderly population, advanced healthcare infrastructure, and high demand for medicines and treatments addressing age-related conditions. Increasing prevalence of chronic diseases, greater healthcare spending, and expanding long-term care services are further supporting market growth.
The US market represents the largest contributor in North America, supported by a rapidly aging population, high healthcare expenditure, and widespread access to specialized treatments. Growing demand for therapies targeting cardiovascular diseases, diabetes, neurological disorders, and other age-related conditions continues to strengthen market growth.
Canada's market is supported by a growing senior population, increasing demand for chronic disease management, and expanding healthcare services for older adults. Rising investments in long-term care and preventive healthcare are also contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 22.35% of the global geriatric medicine market, valued at USD 40.18 billion in 2025, and is projected to register the fastest CAGR of 8.91% during the forecast period. Rapid population aging, improving healthcare infrastructure, and increasing awareness of age-related diseases are driving regional market growth. Rising healthcare expenditure and expanding access to modern medicines are further accelerating demand.
Japan's market is supported by one of the world's most rapidly aging populations, strong healthcare infrastructure, and high demand for treatments focused on elderly care. Increasing use of therapies for chronic and age-related conditions continues to support market growth.
China's market is benefiting from a rapidly expanding elderly population, improving access to healthcare, and increasing government focus on senior care. Growing demand for chronic disease treatments and specialized geriatric services is creating significant market opportunities.
Europe accounted for 28.15% of the global geriatric medicine market, reaching USD 50.60 billion in 2025, and is projected to grow at a CAGR of 6.42% during the forecast period. The regional market is supported by an aging population, established healthcare systems, and increasing demand for treatments for chronic and age-related diseases. Growing investment in elderly care and long-term healthcare services is further supporting market development.
Germany's market is supported by a large elderly population, advanced healthcare infrastructure, and strong demand for chronic disease management. Increasing investment in elderly care facilities and specialized medical services continues to create growth opportunities.
The UK market benefits from growing demand for senior healthcare services, increasing prevalence of age-related diseases, and continued investment in long-term and community-based care. Expanding access to specialized treatments is also supporting market growth.
Middle East & Africa accounted for 4.6% of the global geriatric medicine market, totaling USD 8.27 billion in 2025. Increasing healthcare investments, improving medical infrastructure, and a gradually growing elderly population are supporting market development across the region. Rising awareness of age-related health conditions and expanding access to specialized healthcare are expected to create additional opportunities during the forecast period.
The UAE market is supported by investments in advanced healthcare infrastructure, increasing demand for specialized elderly care, and growing adoption of modern medical treatments. The development of healthcare facilities focused on senior populations is creating additional opportunities.
Africa's market is benefiting from improving healthcare access, increasing life expectancy, and growing demand for chronic disease management. As healthcare infrastructure develops and awareness of elderly health needs increases, opportunities for geriatric medicines and specialized care services are expected to expand.
July 2025: Research into agentic AI for elderly care highlighted opportunities to use AI for personalized health tracking, cognitive care, and environmental support for older adults.
September 2025: The National Centre of Ageing at Banaras Hindu University was nearing completion, with planned specialized services including memory clinics, fall-prevention programs, rehabilitation, and multidisciplinary geriatric care.
February 2026: New market analysis highlighted continued expansion of geriatric medicines, supported by the rising elderly population and increasing prevalence of cardiovascular and other chronic diseases.
March 2026: The Indian government reported that the population aged 60 years and above is projected to rise to 23 crore by 2036, strengthening the long-term need for specialized geriatric healthcare and medicines.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Head
Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.
His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.
Water Electrolysis Market Size, Share, Growth, Analysis, 2034
Vortex Flowmeter Market Size, Share, Growth, Analysis, Report, 2034
North America Hydrophilic Waterstop Market Size, Share by 2034
Asia Pacific Hydrophilic Waterstop Market Size, Trends, Share, Forecast 2034
Europe Nifedipine Market Size, Share & Growth Report by 2034
North America Fogging Machine Market Size, Share Trend Analysis by 2034
We are featured on:
sales@straitsresearch.com